Exposure to Polycyclic Aromatic Hydrocarbons, but Not to Dust or Fluorides, in the Norwegian Aluminum Industry Is Associated With Accelerated Annual Decline in Lung Function
American Journal of Industrial Medicine · 2026-08 · 69 (8) · 674-682
DOI: 10.1002/ajim.70102 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Industrial Medicine, online erschienen am 25.06.2026. Verfasst von Vidar Søyseth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Division, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Polycyclic Aromatic Hydrocarbons, Dust, Occupational Exposure, Aluminum. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
The association between development of chronic airflow limitation and exposures in the aluminum industry is unknown. In a prospective study with nearly 10 years of annual measurements of forced expiratory volume in 1 s (FEV1) and forced vital Capacity (FVC) and concurrent estimates of exposure to dust, total fluorides (TotF) and polycyclic aromatic hydrocarbons (PAH) we investigated the relationship between each of these exposures and annual decline in FEV1 (dFEV1) and FVC (dFVC).
Methods
Estimates of exposure to dust, TotF, and PAH were obtained from random samples of 8‐h shifts using personal samplers at each of seven Norwegian aluminum plants. A total of 18,332 measurements were used to create a job‐exposure matrix. The total number of available spirometries was 20,712 in 3872 workers. Data were analyzed using linear mixed modeling with inverse probability weights for dropouts.
Results
We found that dFEV1 and dFVC increased during follow‐up with linear and quadratic components that were modified by PAH exposure. These linear and quadratic components were estimated at 2.5 mL/year ( p = 0.019) and 4.2 mL/year 2 ( p < 0.001) for dFEV1, and −2.6 mL/year ( p = 0.076) and 5.9 mL/year 2 ( p < 0.001) for dFVC, respectively, per quartile increase in PAH exposure.
Conclusion
We found a significant effect modification of the relationship between dFEV1 and dFVC, and follow‐up time by PAH exposure, indicating that PAH exposure accelerates the annual decline in FEV1 and FVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Division, Akershus University Hospital, Lørenskog, Norway.
- Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, Morgantown, West Virginia, USA.
- National Institute of Public Health, Oslo, Norway.
- Department of Occupational Health Surveillance (NOA), National Institute of Occupational Health.
- Department of Respiratory Medicine, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
ORCID-Profile: Vidar Søyseth, Mohammed Abbas Virji
Zitieren
APA
Søyseth, V., Henneberger, P. K., Lindstrøm, J. C., Virji, M. A., Einvik, G., Bakke, B., & Kongerud, J. (2026). Exposure to Polycyclic Aromatic Hydrocarbons, but Not to Dust or Fluorides, in the Norwegian Aluminum Industry Is Associated With Accelerated Annual Decline in Lung Function. American Journal of Industrial Medicine, 69(8), 674-682. https://doi.org/10.1002/ajim.70102
Vancouver
Søyseth V, Henneberger PK, Lindstrøm JC, Virji MA, Einvik G, Bakke B, et al. Exposure to Polycyclic Aromatic Hydrocarbons, but Not to Dust or Fluorides, in the Norwegian Aluminum Industry Is Associated With Accelerated Annual Decline in Lung Function. American Journal of Industrial Medicine. 2026;69(8):674-682. doi:10.1002/ajim.70102
BibTeX
@article{Syseth2026,
author = {Søyseth, Vidar and Henneberger, Paul K and Lindstrøm, Jonas Christoffer and Virji, Mohammed Abbas and Einvik, Gunnar and Bakke, Berit and Kongerud, Johny},
title = {Exposure to Polycyclic Aromatic Hydrocarbons, but Not to Dust or Fluorides, in the Norwegian Aluminum Industry Is Associated With Accelerated Annual Decline in Lung Function},
journal = {American Journal of Industrial Medicine},
year = {2026},
volume = {69},
number = {8},
pages = {674--682},
doi = {10.1002/ajim.70102}
}
EUVIMED